Camille Gélin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Camille Gélin has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Anne Barlier
Aix Marseille Univ, APHM, INSERM, MMG, MarMaRa institute, La Timone University Hospital, Laboratory of Molecular Biology GEnOPé, BIOGENOPOLE, Marseille, France
11 shared publications - Arnaud Lagarde
AP-HM, Marseille, France
11 shared publications - Aymeric Amelot
Department of Neurosurgery, Hospital Bretonneau, Tours, France
11 shared publications - Catherine Bauters
Service d’Endocrinologie, Hôpital Huriez, CHU de Lille, Lille, France. 21
11 shared publications - Catherine Roche
Laboratory of Molecular Biology, APHM, La Conception Hospital, Marseille, France. 3
11 shared publications - Christine Binquet
Université Bourgogne Europe, CHU Dijon Bourgogne, Centre d’Investigation Clinique, Module épidémiologie Clinique, INSERM, CIC1432 , Côte d'Or, 21000 Dijon
11 shared publications
Latest Publications
- Open Access
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1
Sporadic non-meningothelial meningiomas characteristics
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1
Sporadic non-meningothelial meningiomas characteristics
- Open Access
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1
Sporadic ependymomas characteristics
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1
Sporadic ependymomas characteristics
- Open Access
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1
MEN1 loss of heterozygosity in meningiomas of patients #8, #15 and #16. Electropherogram of Sanger sequencing on tumor DNA showing falsely homozygous MEN1 pathogenic variants due to loss of heterozygosity at a somatic level. Patient #8: c.1037_1038delCT, p.(Thr346SerfsTer20), patient #15: c.249_252delGTCT, p.(Ile85SerfsTer33), patient #16: c.515A>T, p.(Asp172Val)
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1
MEN1 loss of heterozygosity in meningiomas of patients #8, #15 and #16. Electropherogram of Sanger sequencing on tumor DNA showing falsely homozygous MEN1 pathogenic variants due to loss of heterozygosity at a somatic level. Patient #8: c.1037_1038delCT, p.(Thr346SerfsTer20), patient #15: c.249_252delGTCT, p.(Ile85SerfsTer33), patient #16: c.515A>T, p.(Asp172Val)
- Open Access
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1
Sporadic non-meningothelial meningiomas characteristics
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1
Sporadic non-meningothelial meningiomas characteristics
- Open Access
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1
Sporadic meningothelial meningiomas characteristics
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1
Sporadic meningothelial meningiomas characteristics
- Open Access
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1
Sporadic meningothelial meningiomas characteristics
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1
Sporadic meningothelial meningiomas characteristics
- Open Access
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Data S1 from A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1
Detailed including criteria, Registering process, and Legal aspects
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data S1 from A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1
Detailed including criteria, Registering process, and Legal aspects
- Open Access
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Data S1 from A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1
Detailed including criteria, Registering process, and Legal aspects
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data S1 from A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1
Detailed including criteria, Registering process, and Legal aspects
- Open Access
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1
Sporadic ependymomas characteristics
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1
Sporadic ependymomas characteristics
- Open Access
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1
MEN1 loss of heterozygosity in meningiomas of patients #8, #15 and #16. Electropherogram of Sanger sequencing on tumor DNA showing falsely homozygous MEN1 pathogenic variants due to loss of heterozygosity at a somatic level. Patient #8: c.1037_1038delCT, p.(Thr346SerfsTer20), patient #15: c.249_252delGTCT, p.(Ile85SerfsTer33), patient #16: c.515A>T, p.(Asp172Val)
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1
MEN1 loss of heterozygosity in meningiomas of patients #8, #15 and #16. Electropherogram of Sanger sequencing on tumor DNA showing falsely homozygous MEN1 pathogenic variants due to loss of heterozygosity at a somatic level. Patient #8: c.1037_1038delCT, p.(Thr346SerfsTer20), patient #15: c.249_252delGTCT, p.(Ile85SerfsTer33), patient #16: c.515A>T, p.(Asp172Val)